These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11103753)

  • 1. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats.
    Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects.
    Latif F; Tandon S; Obeleniene R; Hankins SR; Berlowitz MS; Ennezat PV; Le Jemtel TH
    J Card Fail; 2001 Sep; 7(3):265-8. PubMed ID: 11561228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of angiotensin II on inflammation mediators in healthy subjects].
    Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
    Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
    Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
    Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; Pelà GM; Novarini A; Cabassi A; Montanari A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
    Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.
    Willemsen JM; Westerink JW; Dallinga-Thie GM; van Zonneveld AJ; Gaillard CA; Rabelink TJ; de Koning EJ
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):6-12. PubMed ID: 17261957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
    Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
    Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):630-4. PubMed ID: 9205777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
    Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.
    Schuller-Petrovic S; Siedler S; Kern T; Meinhart J; Schmidt K; Brunner F
    Br J Pharmacol; 1997 Oct; 122(4):772-8. PubMed ID: 9375976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation.
    Bo Yang ; Chen YD; Li TD; Feng QZ
    J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):119-23. PubMed ID: 20093323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.